658 related articles for article (PubMed ID: 30827526)
21. Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.
Muntner P; Carey RM; Gidding S; Jones DW; Taler SJ; Wright JT; Whelton PK
J Am Coll Cardiol; 2018 Jan; 71(2):109-118. PubMed ID: 29146532
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
[TBL] [Abstract][Full Text] [Related]
23. Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk.
Quinn MM; Kao CN; Ahmad A; Lenhart N; Shinkai K; Cedars MI; Huddleston HG
Fertil Steril; 2016 Oct; 106(5):1244-1251. PubMed ID: 27445197
[TBL] [Abstract][Full Text] [Related]
24. Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Macut D; Damjanovic S; Panidis D; Spanos N; Glisic B; Petakov M; Rousso D; Kourtis A; Bjekic J; Milic N
Eur J Endocrinol; 2006 Jul; 155(1):131-6. PubMed ID: 16793959
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
[TBL] [Abstract][Full Text] [Related]
26. Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.
Pirwany IR; Fleming R; Greer IA; Packard CJ; Sattar N
Clin Endocrinol (Oxf); 2001 Apr; 54(4):447-53. PubMed ID: 11318779
[TBL] [Abstract][Full Text] [Related]
27. Subclinical hypothyroidism in young women with polycystic ovary syndrome: an analysis of clinical, hormonal, and metabolic parameters.
Benetti-Pinto CL; Berini Piccolo VR; Garmes HM; Teatin Juliato CR
Fertil Steril; 2013 Feb; 99(2):588-92. PubMed ID: 23103018
[TBL] [Abstract][Full Text] [Related]
28. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
29. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
Coviello AD; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
[TBL] [Abstract][Full Text] [Related]
30. Changes in the prevalence of measures associated with hypertension among Iranian adults according to classification by ACC/AHA guideline 2017.
Mirzaei M; Mirzaei M; Mirzaei M; Bagheri B
BMC Cardiovasc Disord; 2020 Aug; 20(1):372. PubMed ID: 32799819
[TBL] [Abstract][Full Text] [Related]
31. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
32. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
Daghestani MH
Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
[TBL] [Abstract][Full Text] [Related]
34. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
Joham AE; Boyle JA; Zoungas S; Teede HJ
Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
[TBL] [Abstract][Full Text] [Related]
35. Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome.
Daan NM; Koster MP; Steegers-Theunissen RP; Eijkemans MJ; Fauser BC
Fertil Steril; 2017 Jan; 107(1):261-268.e3. PubMed ID: 28228318
[TBL] [Abstract][Full Text] [Related]
36. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
37. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
Ságodi L; Lombay B; Vámosi I; Barkai L
Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovaries and associated clinical and biochemical features in young women.
Michelmore KF; Balen AH; Dunger DB; Vessey MP
Clin Endocrinol (Oxf); 1999 Dec; 51(6):779-86. PubMed ID: 10619984
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study.
Poudel B; Booth JN; Sakhuja S; Moran AE; Schwartz JE; Lloyd-Jones DM; Lewis CE; Shikany JM; Shimbo D; Muntner P
J Hypertens; 2019 Jul; 37(7):1401-1410. PubMed ID: 31145711
[TBL] [Abstract][Full Text] [Related]
40. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
